The compound binds and blocks farnesyl diphosphate synthase in the HMG-CoA pathway (IC50 = 460 nM for recombinant human FPPS). It causes macrophage apoptosis and inhibits prenylation and sterol biosynthesis in purified osteoclasts.
The compound binds and blocks farnesyl diphosphate synthase in the HMG-CoA pathway (IC50 = 460 nM for recombinant human FPPS). It causes macrophage apoptosis and inhibits prenylation and sterol biosynthesis in purified osteoclasts.
体内研究
Alendronate (1.5E-10-1.5E-7 M, administered by single intraventricular injection on the 7th day of embryonic development, exposed for 4 days) sodium can induce skeletal changes in a chicken embryonic development model.
Animal Model:
Viable fertilized chick eggs (7 days)
Dosage:
1.5E-7 M, 1.5E-8 M, 1.5E-9 M, and 1.5E-10 M
Administration:
intra-air cell injection, single dose at embryonic day 7, exposure for 4 days
Result:
Showed an 87.5% viability rate and a 75% viability rate at 1.5E-10 M and other doses, respectively.
Significantly reduced bone morphometric indexes (bone volume (BV) and bone surface (BS)) and cortical thickness in a dose-dependent manner.
Significantly reduced dimensions and diminished mineralization in a concentration-dependent manner.
Significantly increased TNFRSF11B, NF-κB1 and IL-6 levels, and decreased TNFRSF11A, CTSK, COL1A2, SPP1, and SOST levels, compared to control.
分子式
C4H12NNaO7P2
分子量
271.08
CAS号
129318-43-0
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
2-8°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
溶解性数据
In Vitro:
H2O : 25 mg/mL (92.22 mM; ultrasonic and warming and heat to 60°C)